Contineum Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Contineum Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $202k | 14k | 15.00 |
| 2026-03-31 | $31k | 2.5k | 12.46 |
| 2025-03-31 | $36k | 5.2k | 6.98 |
| 2024-12-31 | $416k | 28k | 14.65 |
| 2024-09-30 | $48k | 2.5k | 19.14 |
| 2024-06-30 | $52k | 3.0k | 17.61 |